vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Urban Edge Properties (UE). Click either name above to swap in a different company.

Urban Edge Properties is the larger business by last-quarter revenue ($132.6M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.6%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.

PBYI vs UE — Head-to-Head

Bigger by revenue
UE
UE
1.8× larger
UE
$132.6M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+15.5% gap
PBYI
27.7%
12.2%
UE
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.6%
UE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PBYI
PBYI
UE
UE
Revenue
$75.5M
$132.6M
Net Profit
$22.6M
Gross Margin
69.3%
Operating Margin
22.7%
Net Margin
17.1%
Revenue YoY
27.7%
12.2%
Net Profit YoY
-6.7%
EPS (diluted)
$0.26
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
UE
UE
Q1 26
$132.6M
Q4 25
$75.5M
$119.6M
Q3 25
$54.5M
$120.1M
Q2 25
$52.4M
$114.1M
Q1 25
$46.0M
$118.2M
Q4 24
$59.1M
$116.4M
Q3 24
$80.5M
$112.4M
Q2 24
$47.1M
$106.5M
Net Profit
PBYI
PBYI
UE
UE
Q1 26
$22.6M
Q4 25
$12.4M
Q3 25
$8.8M
$14.9M
Q2 25
$5.9M
$58.0M
Q1 25
$3.0M
$8.2M
Q4 24
$30.1M
Q3 24
$20.3M
$9.1M
Q2 24
$-4.5M
$30.8M
Gross Margin
PBYI
PBYI
UE
UE
Q1 26
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Operating Margin
PBYI
PBYI
UE
UE
Q1 26
Q4 25
22.7%
11.3%
Q3 25
17.6%
13.4%
Q2 25
12.7%
53.9%
Q1 25
8.7%
7.6%
Q4 24
22.6%
27.6%
Q3 24
27.4%
8.9%
Q2 24
-4.6%
30.6%
Net Margin
PBYI
PBYI
UE
UE
Q1 26
17.1%
Q4 25
10.4%
Q3 25
16.2%
12.4%
Q2 25
11.2%
50.8%
Q1 25
6.5%
6.9%
Q4 24
25.9%
Q3 24
25.2%
8.1%
Q2 24
-9.6%
28.9%
EPS (diluted)
PBYI
PBYI
UE
UE
Q1 26
$0.18
Q4 25
$0.26
$0.09
Q3 25
$0.17
$0.12
Q2 25
$0.12
$0.46
Q1 25
$0.06
$0.07
Q4 24
$0.40
$0.25
Q3 24
$0.41
$0.07
Q2 24
$-0.09
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
UE
UE
Cash + ST InvestmentsLiquidity on hand
$97.5M
$50.0M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$1.4B
Total Assets
$216.3M
$3.4B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
UE
UE
Q1 26
$50.0M
Q4 25
$97.5M
$48.9M
Q3 25
$94.4M
$77.8M
Q2 25
$96.0M
$53.0M
Q1 25
$93.2M
$48.0M
Q4 24
$101.0M
$41.4M
Q3 24
$96.7M
$67.9M
Q2 24
$96.8M
$78.6M
Total Debt
PBYI
PBYI
UE
UE
Q1 26
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Stockholders' Equity
PBYI
PBYI
UE
UE
Q1 26
$1.4B
Q4 25
$130.3M
$1.4B
Q3 25
$115.3M
$1.4B
Q2 25
$104.7M
$1.4B
Q1 25
$97.1M
$1.4B
Q4 24
$92.1M
$1.4B
Q3 24
$71.1M
$1.3B
Q2 24
$48.5M
$1.3B
Total Assets
PBYI
PBYI
UE
UE
Q1 26
$3.4B
Q4 25
$216.3M
$3.3B
Q3 25
$202.9M
$3.3B
Q2 25
$194.9M
$3.3B
Q1 25
$196.2M
$3.3B
Q4 24
$213.3M
$3.3B
Q3 24
$220.7M
$3.2B
Q2 24
$205.0M
$3.2B
Debt / Equity
PBYI
PBYI
UE
UE
Q1 26
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
UE
UE
Operating Cash FlowLast quarter
$14.4M
$39.1M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
1.5%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
UE
UE
Q1 26
$39.1M
Q4 25
$14.4M
$182.7M
Q3 25
$9.7M
$55.7M
Q2 25
$14.1M
$43.5M
Q1 25
$3.6M
$32.6M
Q4 24
$15.6M
$153.2M
Q3 24
$11.0M
$36.6M
Q2 24
$1.0M
$41.2M
Free Cash Flow
PBYI
PBYI
UE
UE
Q1 26
Q4 25
$14.4M
$81.8M
Q3 25
$9.7M
$26.1M
Q2 25
$14.1M
$19.6M
Q1 25
$3.6M
$11.9M
Q4 24
$15.6M
$42.5M
Q3 24
$11.0M
$12.2M
Q2 24
$1.0M
$19.9M
FCF Margin
PBYI
PBYI
UE
UE
Q1 26
Q4 25
19.1%
68.4%
Q3 25
17.7%
21.7%
Q2 25
26.8%
17.2%
Q1 25
7.7%
10.0%
Q4 24
26.4%
36.6%
Q3 24
13.7%
10.8%
Q2 24
2.1%
18.6%
Capex Intensity
PBYI
PBYI
UE
UE
Q1 26
1.5%
Q4 25
0.0%
84.4%
Q3 25
0.0%
24.6%
Q2 25
0.0%
20.9%
Q1 25
0.1%
17.5%
Q4 24
0.0%
95.1%
Q3 24
0.0%
21.7%
Q2 24
0.0%
20.1%
Cash Conversion
PBYI
PBYI
UE
UE
Q1 26
1.73×
Q4 25
14.71×
Q3 25
1.10×
3.73×
Q2 25
2.41×
0.75×
Q1 25
1.21×
3.97×
Q4 24
5.09×
Q3 24
0.54×
4.03×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

UE
UE

Rental revenue$124.2M94%
Other$8.4M6%

Related Comparisons